What Is CBG? Why This "Minor" Cannabinoid Is Showing Up in Daytime Products

CBG, short for cannabigerol, is a minor cannabinoid found in cannabis. It is called “minor” because most cannabis products contain much smaller amounts of CBG than major cannabinoids like THC or CBD. Even so, CBG is becoming more visible in gummies, tinctures, capsules, beverages, vapes, and flower products marketed for daytime use. Many shoppers are searching “what is CBG?” because it is often described as non-intoxicating, functional, clear-headed, or balanced. A 2024 review describes CBG as a non-psychoactive cannabinoid found in cannabis, while a 2026 critical review notes that its acidic form, CBGA, are emerging as key non-psychoactive phytocannabinoids with distinctive pharmacological properties.

This cannabinoid is sometimes called the “mother cannabinoid,” but the more accurate term is that CBGA is a major precursor molecule in the cannabis plant. CBGA can serve as a starting point for other cannabinoids, including THC, CBD, CBC, and CBN, depending on the plant’s genetics and chemistry. CBG itself forms when CBGA converts through decarboxylation. In simple terms, CBG is part of the cannabinoid family tree, not just another version of THC or CBD. That is why it has become interesting to growers, extractors, and product formulators looking beyond the standard THC-versus-CBD conversation.

This popular cannabinoid is showing up in daytime products because it is usually positioned differently than THC-heavy or sleep-focused formulas. THC is the cannabinoid most associated with intoxication, while CBG is generally marketed as non-intoxicating and more functional. That makes it appealing for products built around focus, mood, balance, daytime calm, or general wellness routines. The important caution is that marketing language can run ahead of the science. CBG may be promising, but it should not be treated as a proven cure for anxiety, pain, inflammation, attention issues, or any medical condition. The FDA states that, aside from specific approved prescription drugs, it has not approved cannabis, cannabis-derived, or CBD products currently available on the market for treating diseases or conditions.

The human research on CBG is still early, but it is growing. A 2024 double-blind, placebo-controlled crossover trial tested 20 mg of hemp-derived CBG in 34 healthy adults and found reductions in anxiety and stress compared with placebo, with no evidence of subjective drug effects or impairment in that study. The same paper emphasized that human research on CBG has been limited and that more clinical trials are needed. A 2026 review reached a similar conclusion: preclinical work suggests CBG and CBGA may have anti-inflammatory, neuroprotective, and analgesic effects, but human data remain limited, especially for isolated CBG with clear clinical endpoints.

For shoppers, the best way to evaluate a CBG product is to read the full label and COA instead of relying on the word “CBG” alone. Check how many milligrams of CBG are in each serving, whether the product also contains THC, CBD, CBN, CBC, or terpenes, and whether the lab report includes potency and contaminant testing. A CBG gummy with no THC is different from a full-spectrum CBG product that includes Delta-9 THC or other intoxicating cannabinoids. Product type matters too. A tincture, edible, beverage, vape, and flower product can all have different onset times, durations, and effects. If drug testing is a concern, pay close attention to THC content because “CBG” does not automatically mean “THC-free.”

CBG is a minor, generally non-intoxicating cannabinoid that is becoming popular in daytime cannabis and hemp products, but the science is still developing. It may be one of the most interesting cannabinoids to watch, especially as brands move beyond THC percentage and CBD-only formulas. Still, consumers should be careful with big claims, read lab results, start with a low serving, and understand whether the product contains any THC. Any THC-containing product can cause impairment, and CDC guidance notes that cannabis use can affect memory, attention, decision-making, coordination, emotions, and reaction time.